Enliven Therapeutics, Inc.

ELVN Healthcare Biotechnology

EPS
0.00%
Free cash flow
−8.34%

Quarter to June 2026, against a year earlier

48.95 4.16 +9.29%
Market cap
$3.3B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Enliven Therapeutics, Inc. (ELVN) Operating margin

Alert me on Operating margin

Enliven Therapeutics, Inc.'s operating margin over the twelve months to 30 June 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from 0.00% (fiscal 2025) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 0.00% 0.00
FY2024 0.00% 0.00
FY2023 0.00% 0.00
FY2022 0.00% 0.00
FY2021 0.00% 0.00
FY2020 0.00% 0.00
FY2019 0.00% 0.00
FY2018 0.00% 0.00
FY2017 0.00% —

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 0.00% 0.00
Mar 2026 0.00% 0.00
Dec 2025 0.00% 0.00
Sep 2025 0.00% 0.00
26 more quarters

Against its own ten years

Low 0.00% High 0.00%
Ten-year median 0.00%
Current reading's percentile 100

Operating margin against peers

Company Operating margin
ACAD ACADIA Pharmaceuticals Inc. compare 10.2%
ELVN Enliven Therapeutics, Inc. 0.00%
DYN Dyne Therapeutics, Inc. compare 0.00%
CELC Celcuity, Inc. compare 0.00%
VKTX Viking Therapeutics, Inc. compare 0.00%
TARS Tarsus Pharmaceuticals, Inc. compare −102.0%
VRDN Viridian Therapeutics, Inc. compare −1,781.4%
DNLI Denali Therapeutics Inc. compare −2,349.0%
TLX Telix Pharmaceuticals Limited compare —
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on ELVN